Evidence for Nonlinear Pharmacokinetics of Methotrexate in the Rat
- 1 January 1982
- journal article
- research article
- Published by S. Karger AG in Pharmacology
- Vol. 25 (1) , 51-56
- https://doi.org/10.1159/000137723
Abstract
Three doses (0.31, 3.1 and 31 mg/kg) of methotrexate (MTX) were given intravenously to rats. The resulting concentration-time curves in plasma (normalized by dividing the plasma concentration by a multiple of the dose) were not superimposable, indicating nonlinear plasma pharmacokinetics. In liver, kidney, bone marrow and stomach a tissue-specific, very slowly (or not measurably) decreasing terminal plateau phase could be observed after administration of all three doses. This was explained by a strong binding of MTX to dihydrofolate reductase. The ratio, exchangeable MTX in tissue/plasma concentration, increased in liver and kidney with time after the higher doses, which is in accord with saturable transport to tissues.Keywords
This publication has 6 references indexed in Scilit:
- Dose dependent methotrexate elimination following bolus intravenous injectionEuropean Journal of Clinical Pharmacology, 1980
- Competitive Inhibition between Folic Acid and Methotrexate for Transport Carrier in the Rat Small IntestineJournal of Pharmaceutical Sciences, 1979
- RENAL TUBULAR TRANSPORT OF METHOTREXATE IN THE RHESUS-MONKEY AND DOG1979
- A pharmacokinetic model for high-dose methotrexate infusions in manJournal of Pharmacokinetics and Biopharmaceutics, 1977
- PH-DEPENDENT, CARRIER-MEDIATED TRANSPORT-SYSTEM FOR FOLATE ANALOG, AMETHOPTERIN, IN RAT JEJUNUM1977
- Biliary Secretion of Methotrexate in Rats and Its Inhibition by ProbenecidJournal of Pharmaceutical Sciences, 1976